nib.
Briefed. Not Overwhelmed.
News In Brief, Nownibnow by ravenso
Natco Pharma raises eGenesis investment to $16.7 million, backs gene-edited organ researchPhoto: CNBC-TV18 Markets
BUSINESSCNBC-TV18 Markets ยท 7 hours agoLive

Natco Pharma raises eGenesis investment to $16.7 million, backs gene-edited organ research

Reported by CNBC-TV18 Markets, not nibnow. We are not the publisher of this story, only the source is.

FROM THE SOURCE

Natco Pharma has raised its investment in US biotech eGenesis to $16.7 million from $14 million, as it backs research aimed at using gene-edited pig organs for human transplants.

Read the full story at CNBC-TV18 Markets